Philippe Degive

Chief Executive Officer at

Investsud SA

Health Technology

Finance

Consumer Services

Profile

Philippe Degive is currently the CEO at Investsud SA. He is also a Non-Executive Director at Ogeda SA, a Director at Bridge2Health SA, and an Investment Manager at Société Régionale d'Investissement de Wallonie SA since 2008.
Previously, he held positions as a Director at PROMETHERA Biosciences SA, iSTAR Medical SA, Novadip Biosciences SA, Pluriomics BV, and Ncardia SA. Mr. Degive obtained an MBA from the University of Liege in 1994.

Philippe Degive active positions

Companies	Position	Start
Ogeda SA Ogeda SA Pharmaceuticals: MajorHealth Technology Discovers and develops small molecule drugs	Director/Board Member	-
Bridge2Health SA Bridge2Health SA BiotechnologyHealth Technology Provides biomedical translational research services	Director/Board Member	-
Société Régionale d'Investissement de Wallonie SA Société Régionale d'Investissement de Wallonie SA Investment ManagersFinance SRIW invests in companies located in Belgium. The firm focuses on a broad range of sectors. It participates in equity and debt in seed, early, later, growth, MBI & MBO transactions. The firm acquires majority interests for certain transactions.	Private Equity Investor	30/06/2008
Investsud SA Investsud SA Investment ManagersFinance INVESTSUD is an active manager which invests in family-owned small and medium-sized companies across the industrial, commercial and services sectors operating in the Belgian provinces of Liège, Namur or Luxembourg. They do not invest in failing companies. The firm seeks to invest EUR 0.1-3 million in companies with a quality project and significant profit potential. They typically take minority stakes and seek board representation, partnering with management to create value through a range of support activities including sourcing funding structures that provide maximum security to the shareholders, helping them out of isolation, preparing them for estate planning or assisting them in an investment or takeover plan.	Chief Executive Officer	30/04/2023

All active positions of Philippe Degive

Former positions of Philippe Degive

Companies	Position	End
PROMETHERA Biosciences SA PROMETHERA Biosciences SA Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes cell therapy products to treat liver diseases	Director/Board Member	05/04/2018
Ncardia SA Ncardia SA Miscellaneous Commercial ServicesCommercial Services Operates as a drug discovery research organization	Director/Board Member	-
Novadip Biosciences SA Novadip Biosciences SA BiotechnologyHealth Technology Operates as a advanced biopharmaceutical company that develops cell-based therapies to treat patients with critical size bone defects and severe bone diseases	Director/Board Member	01/01/1901
Pluriomics BV Pluriomics BV BiotechnologyHealth Technology Research and development of pharmaceuticals	Director/Board Member	-
iSTAR Medical SA iSTAR Medical SA Medical SpecialtiesHealth Technology Develops innovative implants for eye care solutions	Director/Board Member	-

See the detail of Philippe Degive's experience

Training of Philippe Degive

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Philippe Degive's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	10
Société Régionale d'Investissement de Wallonie SA Société Régionale d'Investissement de Wallonie SA Investment ManagersFinance SRIW invests in companies located in Belgium. The firm focuses on a broad range of sectors. It participates in equity and debt in seed, early, later, growth, MBI & MBO transactions. The firm acquires majority interests for certain transactions.	Finance
Ogeda SA Ogeda SA Pharmaceuticals: MajorHealth Technology Discovers and develops small molecule drugs	Health Technology
University of Liege University of Liege Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Investsud SA Investsud SA Investment ManagersFinance INVESTSUD is an active manager which invests in family-owned small and medium-sized companies across the industrial, commercial and services sectors operating in the Belgian provinces of Liège, Namur or Luxembourg. They do not invest in failing companies. The firm seeks to invest EUR 0.1-3 million in companies with a quality project and significant profit potential. They typically take minority stakes and seek board representation, partnering with management to create value through a range of support activities including sourcing funding structures that provide maximum security to the shareholders, helping them out of isolation, preparing them for estate planning or assisting them in an investment or takeover plan.	Finance
PROMETHERA Biosciences SA PROMETHERA Biosciences SA Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes cell therapy products to treat liver diseases	Health Technology
Bridge2Health SA Bridge2Health SA BiotechnologyHealth Technology Provides biomedical translational research services	Health Technology
iSTAR Medical SA iSTAR Medical SA Medical SpecialtiesHealth Technology Develops innovative implants for eye care solutions	Health Technology
Novadip Biosciences SA Novadip Biosciences SA BiotechnologyHealth Technology Operates as a advanced biopharmaceutical company that develops cell-based therapies to treat patients with critical size bone defects and severe bone diseases	Health Technology
Pluriomics BV Pluriomics BV BiotechnologyHealth Technology Research and development of pharmaceuticals	Health Technology
Ncardia SA Ncardia SA Miscellaneous Commercial ServicesCommercial Services Operates as a drug discovery research organization	Commercial Services